315 related articles for article (PubMed ID: 31852546)
1. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.
Abdel Rida N; Mohamed Ibrahim MI; Babar ZUD
BMC Health Serv Res; 2019 Dec; 19(1):973. PubMed ID: 31852546
[TBL] [Abstract][Full Text] [Related]
2. Availability, prices and affordability of selected essential medicines in Jordan: a national survey.
Alefan Q; Amairi R; Tawalbeh S
BMC Health Serv Res; 2018 Oct; 18(1):787. PubMed ID: 30340486
[TBL] [Abstract][Full Text] [Related]
3. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
[TBL] [Abstract][Full Text] [Related]
4. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
5. Measuring access to medicines: a survey of prices, availability and affordability in Shaanxi province of China.
Jiang M; Yang S; Yan K; Liu J; Zhao J; Fang Y
PLoS One; 2013; 8(8):e70836. PubMed ID: 23936471
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
[TBL] [Abstract][Full Text] [Related]
7. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy.
Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S
Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937
[TBL] [Abstract][Full Text] [Related]
8. Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria.
Orubu ESF; Robert FO; Samuel M; Megbule D
Health Policy Plan; 2019 Dec; 34(Supplement_3):iii20-iii26. PubMed ID: 31816074
[TBL] [Abstract][Full Text] [Related]
9. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
[TBL] [Abstract][Full Text] [Related]
10. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
Osuafor NG; Ukwe CV; Okonta M
PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799
[TBL] [Abstract][Full Text] [Related]
12. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.
Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R
Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012
[TBL] [Abstract][Full Text] [Related]
13. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X
BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137
[TBL] [Abstract][Full Text] [Related]
14. Availability, prices and affordability of essential medicines in Zhejiang Province, China.
Dong Z; Tao Q; Yan B; Sun G
PLoS One; 2020; 15(11):e0241761. PubMed ID: 33232336
[TBL] [Abstract][Full Text] [Related]
15. Availability, prices and affordability of essential medicines: A cross-sectional survey in Hanam province, Vietnam.
Nguyen HTT; Dinh DX; Nguyen TD; Nguyen VM
PLoS One; 2021; 16(11):e0260142. PubMed ID: 34793554
[TBL] [Abstract][Full Text] [Related]
16. Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology.
Kasonde L; Tordrup D; Naheed A; Zeng W; Ahmed S; Babar ZU
BMC Health Serv Res; 2019 Jun; 19(1):383. PubMed ID: 31196078
[TBL] [Abstract][Full Text] [Related]
17. Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico.
Moye-Holz D; Ewen M; Dreser A; Bautista-Arredondo S; Soria-Saucedo R; van Dijk JP; Reijneveld SA; Hogerzeil HV
BMC Health Serv Res; 2020 May; 20(1):424. PubMed ID: 32410676
[TBL] [Abstract][Full Text] [Related]
18. Prices, Availability and Affordability of Medicines with Value-Added Tax Exemption: A Cross-Sectional Survey in the Philippines.
Lambojon K; Chang J; Saeed A; Hayat K; Li P; Jiang M; Atif N; Desalegn GK; Khan FU; Fang Y
Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32708060
[TBL] [Abstract][Full Text] [Related]
19. Prices, availability and affordability of medicines in Rwanda.
Bizimana T; Kayumba PC; Heide L
PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
[TBL] [Abstract][Full Text] [Related]
20. Availability, Price, and Affordability of Selected Essential Medicines for Chronic Diseases in 11 Countries of the Asia Pacific Region: A Secondary Analysis.
Wang H; Sun Q; Vitry A; Nguyen TA
Asia Pac J Public Health; 2017 May; 29(4):268-277. PubMed ID: 28397532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]